GLYCOPYRRONIUM INHALER (Seebri Breezhaler®)

Clinical Indication

COPD

Following review by LLR Respiratory Prescribing Group and Therapeutic Advisory Service

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.